Amphastar Pharmaceuticals, Inc. Quarterly Nonoperating Income (Expense) in USD from Q2 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Amphastar Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2013 to Q3 2024.
  • Amphastar Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$9.37M, a 3.58% decline year-over-year.
  • Amphastar Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$27.1M, a 183% decline year-over-year.
  • Amphastar Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was -$25.6M, a 400% decline from 2022.
  • Amphastar Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was $8.54M, a 40.1% decline from 2021.
  • Amphastar Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was $14.3M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$27.1M -$9.37M -$324K -3.58% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$26.8M -$4.97M -$886K -21.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 -$25.9M -$134K -$270K -199% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$25.6M -$12.6M -$16.1M -469% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 -$9.57M -$9.04M -$8.41M -1331% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$1.16M -$4.09M -$2.42M -144% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $1.26M $136K -$7.28M -98.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $8.54M $3.43M +$518K +17.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $8.03M -$632K -$13.5M -105% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $21.5M -$1.67M -$5.33M -146% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $26.9M $7.42M +$12.6M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $14.3M $2.91M +$12.5M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $1.72M $12.9M +$9.32M +262% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$7.6M $3.66M +$2.24M +158% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$9.83M -$5.19M -$3.52M -210% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$6.32M -$9.62M -$11.1M -773% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $4.73M $3.56M +$4.38M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $351K $1.42M -$58.7M -97.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $59.1M -$1.68M -$1.21M -263% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $60.3M $1.43M +$2.39M Oct 1, 2019 Dec 31, 2019 10-K 2022-03-11
Q3 2019 $57.9M -$822K -$846K -3525% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $58.7M $60.1M +$61.4M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$2.65M -$461K -$1.35M -152% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$1.3M -$956K -$1.56M -259% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-15
Q3 2018 $254K $24K -$805K -97.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $1.06M -$1.26M -$2.25M -227% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $3.31M $888K +$788K +788% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $2.52M $601K +$714K Oct 1, 2017 Dec 31, 2017 10-K 2020-03-16
Q3 2017 $1.8M $829K +$625K +306% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $1.18M $988K +$1.57M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$387K $100K +$359K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$746K -$113K +$3.92M +97.2% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-15
Q3 2016 -$4.67M $204K +$732K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$5.4M -$578K -$609K -1965% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$4.79M -$259K -$1.32M -124% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$3.47M -$4.03M -$5.24M -434% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-14
Q3 2015 $1.78M -$528K -$361K -216% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $2.14M $31K +$735K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $1.4M $1.06M +$1.57M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$165K $1.21M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-15
Q3 2014 -$167K -$276K -253% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 -$704K -$641K -1017% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$502K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q3 2013 $109K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 -$63K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.